Mosaic与Perimount二尖瓣生物瓣长期结局:940例植入17年随访
单中心回顾性研究比较Mosaic猪源二尖瓣与Carpentier-Edwards牛心包二尖瓣的长期结局,共纳入940例患者(猪源463例,牛源477例),倾向匹配802例分析。随访99%完整,总计6045患者年。结果显示15年生存率两组无显著差异,但牛心包瓣结构性瓣膜衰败的再手术累积发生率更高、发生更早,尤其在65岁以下患者中更明显。
要点
- 倾向匹配后15年生存率猪源瓣24.0% vs 牛源瓣16.5%,无显著差异(P=.67)
- 15年结构性瓣膜衰败再手术累积发生率猪源瓣7.9% vs 牛源瓣13.2%(P<.001)
- 65岁以下患者15年衰败率猪源瓣15.8% vs 牛源瓣30.2%(P=.009)
核心结论
- 在长期随访中,65岁以下接受二尖瓣置换的患者,牛心包瓣比猪源瓣发生结构性瓣膜衰败更早且更频繁。
研究设计与样本
- 单中心回顾性研究,2001年至2017年共940例二尖瓣生物瓣置换患者,猪源瓣463例(49.3%),牛心包瓣477例(50.7%)。
- 随访至2018年8月,随访完整率99%(929例),总计6045患者年(平均6.4±4.5年),采用倾向匹配802例进行结局分析。
主要发现
- 940例患者手术死亡率为5.4%(n=51),术后卒中发生率为2.1%(n=20)。
- 倾向匹配患者10年和15年总生存率分别为49.7%(95%CI 45.5%-53.7%)和23.3%(95%CI 17.9%-29.3%)。
- 15年生存率猪源瓣为24.0%(95%CI 18.0%-30.5%),牛心包瓣为16.5%(95%CI 5.5%-32.6%),差异无统计学意义(P=.67)。
- 15年结构性瓣膜衰败再手术累积发生率猪源瓣为7.9%(95%CI 4.7%-12.3%),牛心包瓣为13.2%(95%CI 8.1%-19.5%),差异有统计学意义(P<.001)。
- 65岁以下患者15年结构性瓣膜衰败率猪源瓣为15.8%(95%CI 7.4%-27.0%),牛心包瓣为30.2%(95%CI 15.1%-46.8%),差异有统计学意义(P=.009)。
关键数值与推荐
- 结构性瓣膜衰败再手术平均时间:猪源瓣11.1±2.3年,牛心包瓣6.8±2.3年(P<.001)。
临床怎么用
- 对于65岁以下需行二尖瓣置换的患者,选择生物瓣时应考虑牛心包瓣结构性衰败发生更早且更频繁,猪源瓣可能具有更优的长期耐久性。
局限性
- 本研究为单中心回顾性设计,可能存在选择偏倚和未测量混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of this study was to compare long-term outcomes of Mosaic (Medtronic, Minneapolis, MN) porcine mitral valves to Carpentier-Edwards (Edwards Lifesciences, Irving, CA) bovine pericardial mitral valves. METHODS: From 2001 through 2017 at a single institution, 940 patients received a mitral bioprosthesis, of which 463 (49.3%) were porcine and 477 (50.7%) were bovine pericardial. Retrospective review of the procedure and the postoperative clinical course, including echocardiography, through August 2018 were analyzed. All consecutive mitral valve replacements over the study period were included. Follow-up was 99% (929 patients) complete for a total of 6045 patient-years (mean, 6.4 ± 4.5 years). A propensity-matched cohort of 802 mitral bioprosthesis was used for outcome analyses. RESULTS: Operative mortality of the 940 patients was 5.4% (n = 51) and incidence of postoperative stroke was 2.1% (n = 20). Overall survival of the propensity-matched patients at 10 and 15 years was 49.7% (95% confidence interval [CI] 45.5%-53.7%) and 23.3% (95% CI 17.9%-29.3%), respectively. Survival at 15 years was 24.0% (95% CI 18.0%-30.5%) for porcine and 16.5% (95% CI 5.5%-32.6%) for bovine implants, which was not significantly different (P = .67). Overall cumulative incidence for reoperative structural valve deterioration at 15 years was 7.9% (95% CI 4.7%-12.3%) for porcine valves versus 13.2% (95% CI 8.1%-19.5%) for pericardial valves (P < .001). For patients age younger than 65 years, structural valve deterioration at 15 years was 15.8% (95% CI 7.4%-27.0%) versus 30.2% (95% CI 15.1%-46.8%) for porcine and pericardial valves, respectively (P = .009). Overall average time to reoperation for structural valve deterioration for porcine valves was 11.1 ± 2.3 years vs 6.8 ± 2.3 years for bovine pericardial valves (P < .001). CONCLUSIONS: In long-term follow-up, of patients younger than 65 years of age undergoing mitral valve replacement, bovine pericardial valves experienced earlier and more frequent structural valve deterioration than porcine valves.
引用
- Beute TJ, Goehler M, Parker J, et al. Long-Term Outcomes of Mosaic Versus Perimount Mitral Replacements: 17-Year Follow-Up of 940 Implants. Ann Thorac Surg. 2019. PMID: 31866480. doi:10.1016/j.athoracsur.2019.10.075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。